Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 456 participants.
Also called NCT02484027
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 456 participants
- Sponsor
- Registry
-
NCT02484027
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02484027. Randomized; no masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS)
- Acronym
- REPAIRS
- Condition
- Infarction, Anterior Cerebral Artery
- Intervention (Drug)
- Rosuvastatin
- Lead sponsor
- Second Affiliated Hospital of Soochow University
- Collaborator
- Taicang No.1 People's hospital
- Collaborator
- AstraZeneca
- Collaborator
- National Natural Science Foundation of China
Record details
- Record id
cardio:ct-nct02484027- Content hash
7ba7b5cde9f8944a2090e4febc38c2af26af69e71f75e8f30f3861cfbd350b0f